Tag: Subsense

2 articles

Industry News

Apple acquires neural-sensor startup Sonera Magnetics

Apple's acquisition of Berkeley-based magnetic-sensor startup Sonera Magnetics, closed in May 2026 and disclosed publicly on 8 September 2026 via the European Commission's Digital Markets Act acquisitions database, is the company's first move from hosting third-party brain-computer interface signals to owning proprietary neural-sensor IP. Sonera builds solid-state acoustically-driven ferromagnetic resonance (ADFMR) magnetometers, a room-temperature alternative to SQUID-based magnetoencephalography (MEG). The company raised US$11 million in seed financing in September 2023 from a lead-heavy syndicate including Founders Fund, Benchmark, Amplify Partners, IVP, Craft Ventures, and 8VC. Deal terms were not disclosed. Sonera's website was taken offline post-acquisition. Apple's prior BCI-adjacent moves were the AirPods ear-canal biosignal patent (filed January 2023), the BCI HID accessibility protocol for iOS 26, iPadOS 26 and visionOS 26 launched with Synchron on 13 May 2025, and hosting of Cognixion's non-invasive EEG clinical trial on Vision Pro from October 2025. Owning Sonera's magnetic-sensor IP puts Apple directly against Meta's Neural Band (surface EMG) and the non-surgical BCI operator field (Merge Labs ultrasound, Subsense nanoparticle, Neurable EEG earbuds).

Sep 9

Industry News

Ray Kurzweil joins nanoparticle-BCI startup Subsense as Product and Vision Advisor

Ray Kurzweil, the futurist and inventor who has argued for two decades that brain-computer interfaces will arrive through molecular-scale machines rather than through skull-drilled implants, has joined Palo Alto-based Subsense as Product and Vision Advisor. Subsense unveiled the appointment on the evening of 2 September 2026 at its Palo Alto headquarters. Subsense, founded 2022 by CEO Tetiana Aleksandrova and Artem Sokolov, is developing a non-surgical BCI based on intranasally-delivered nanoparticles paired with a wearable magnetic-coil headset. The company has raised US$27 million in seed financing led by Sokolov's Golden Falcon Capital and remains in preclinical mouse-model work. The appointment lands one week after Merge Labs and Butterfly Network's chip-supply deal established the ultrasound-BCI industrial base, and adds a molecular modality to the non-surgical BCI landscape.

Sep 4